Stephanie Fitzgerald
Obstetrics & Gynecology · Manistee, MINPI 1609955400
Payments from drug & device makers
Across 84 payments — averaging $36.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Astellas Pharma US Inc$657
- AbbVie$107
- Olympus America Inc.$75
- Gynesonics, Inc.$64
- Bayer$58
- plus $448 from 16 others
What the payments were for
- Travel & lodging$1,31742%
- Food & beverage$1,34944%
- Education$43414%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 23 | $1,691 |
| Astellas Pharma US Inc | 24 | $657 |
| AbbVie(2 entities) | 6 | $107 |
| Olympus America Inc. | 1 | $75 |
| Gynesonics, Inc. | 1 | $64 |
| Bayer | 3 | $58 |
| Myriad Women's Health, Inc. | 2 | $43 |
| Biogen | 2 | $41 |
| Organon | 4 | $41 |
| AMAG Pharmaceuticals, Inc. | 3 | $36 |
| GSK | 1 | $34 |
| Amgen | 2 | $34 |
| Daiichi Sankyo Inc. | 2 | $33 |
| Merck | 2 | $26 |
| Pfizer | 1 | $23 |
| Axonics, Inc. | 1 | $22 |
| Aspira Women's Health Inc | 1 | $21 |
| Radius Health, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $20 |
| Acessa Health Inc. | 1 | $19 |
| BD | 1 | $18 |
| Smith+Nephew | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TruClear$1,153
How this compares
$3,100 in reported general payments places this provider in the 85th percentile of 1,474 obstetrics & gynecology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 66 | $9,422 |
| MyrbetriqMirabegron | 15 | $7,741 |
| PremproEstrogen,con/M-Progest Acet | 12 | $4,077 |
| Risedronate Sodium | 13 | $1,294 |
| Clobetasol Propionate | 43 | $877 |
| Raloxifene Hcl | 13 | $562 |
| ValacyclovirValacyclovir Hcl | 26 | $385 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 26 | $318 |
| Alendronate Sodium | 14 | $119 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $657 | $7,74115 claims |
| PfizerPrempro | $23 | $4,07712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,474 obstetrics & gynecology providers in Michigan.
Other obstetrics & gynecology in Manistee
- Marian FullerManistee$14K
- Haider MahdiDetroit$3.4M
- Andrew WagnerMidland$2M
- Jason BellAnn Arbor$548K
- Jacquelyn RobinsonSaginaw$539K
- Jouhaina MalehDearborn$524K
- Awoniyi AwonugaSouthfield$445K
- Rabbie HannaDetroit$421K
- David EisensteinDetroit$296K
- Duane HeilbronnSaginaw$234K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.